Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path COST Q1 2026 Earnings EPS Falls Short of Estimates on Margin Pressure Anika Therapeutics ANIK Q1 2026 Earnings Surprise EPS Beat Amid Revenue Uncertainty AXP Q1 2026 Earnings EPS Beat of 533 Highlights Resilient Spending Opera Limited OPRA Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher OTIS Q1 2026 Earnings EPS Falls Short of Estimates Amid Mixed Demand